logo
Select company
Select metric
0%Cost of Revenue Margin
VS
Market
84
Sector
78
Industry
53
History
-
$ 11.01Close
$ 4.26 - $ 15.16 52-Week Range
Ticker Information

Ticker

ENTA

Company Name

ENANTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENANTA PHARMACEUTICALS INC - Cost of Revenue Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTA - COGS % Historical data
DateCost of RevenueCost of Revenue MarginRevenues
6/30/2025$ 00%$ 64.81M
3/31/2025$ 00%$ 64.46M
12/31/2024$ 00%$ 66.59M
9/30/2024$ 00%$ 67.64M
6/30/2024$ 00%$ 71.96M
3/31/2024$ 00%$ 72.88M
12/31/2023$ 00%$ 73.62M
9/30/2023$ 00%$ 79.2M
6/30/2023$ 00%$ 80.59M
3/31/2023$ 00%$ 81.18M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENANTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) COGS % stands at 0%.
  • Over the past 5 years, ENANTA PHARMACEUTICALS INC's average COGS % has been 0%.
  • The median COGS % for ENANTA PHARMACEUTICALS INC during this period was 0%
  • ENANTA PHARMACEUTICALS INC reached its highest COGS % over the past 5 years at 0%.
  • The lowest COGS % recorded by ENANTA PHARMACEUTICALS INC in the same timeframe 0%

ENANTA PHARMACEUTICALS INC's COGS % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

COGS % Benchmarks
CompanyCOGS %
THTX : THERATECHNOLOGIES INC 22.28%BDTX : BLACK DIAMOND THERAPEUTICS INC 0%PLX : PROTALIX BIOTHERAPEUTICS INC 42.47%ALEC : ALECTOR INC 0%SGMO : SANGAMO THERAPEUTICS INC 0%CSBR : CHAMPIONS ONCOLOGY INC 51.53%SPRO : SPERO THERAPEUTICS INC 0%CCCC : C4 THERAPEUTICS INC 0%TRDA : ENTRADA THERAPEUTICS INC 0%CELU : CELULARITY INC 44.9%

Definition of Cost of Revenue Margin

[Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
COGS / Revenues
(=) COGS %
COGS % for ENANTA PHARMACEUTICALS INC is calculated as follows: COGS [ $ 0 ] / Revenues [ $ 122.47M ]
(=) COGS % [ 0% ]

ENTA - Cost of Revenue Margin, Last 5 years

0%

Minimum

Sep 30, 2020

0%

Maximum

Sep 30, 2020

0%

Average

0%

Median

COGS % Benchmark Analysis

The chart above depicts the distribution of COGS % for companies in the Total Stock Market. The average COGS % of the companies is 46.91% with a standard deviation of 31.59%.
The following table provides additional summary stats:
COGS % in the Market:
filtered constituents3.81K
min-50.26%
max172.25%
average46.91%
median50.54%
std31.59%